SMS Pharmaceuticals Ltd — Interim / Quarterly Report 2021

Feb 12, 2021

Registered & Corporate Office: Plot No. 72, H. No. 8-2-334/3 & 4, Road No.5, Opp. SBI Executive Enclave, Banjara Hills, Hyderabad - 500 034, Telangana, INDIA. Tel : +91-40-25259999, Fax: +91 -40-2525 9889 CIN : L24239TG1987PLC008066 Email: info@smspharma.com, www.smspharma.com

Date: lih February, 2021

To, The Manager, Corporate Filings Department, BSE Li mited, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400 001

The Manager, Listing Compliance Department, Nationa l Stock Exchange of India Ltd. Exchange Plaza, Plot no. C/ l, G Block, Ba nd ra-Kurla Complex, Ba ndra (El, Mumbai - 400 051.

Security Code: 532815

Symbol: SMSPHARMA

Dea r Sir/Madam,

Sub: Publishing of Financial Results in Newspaper Ref: Regulation 47(1)(~) of SEBI (List ing Obligations & Disclosures Requirements) Regulations, 2015

Further to our intimation dated 10th February, 2021, please find the enclosed herewith copies of the newspaper advertisements published on 11th February, 2021, regarding financial results for quarter a'nd nine months ended as on 31st December, 2020. Please that this information is published within 48 hours of closure of the Board Meeting as specified in Regulation 47(3) of SEBI (Listing obligations & Disclosure Requirements) regulations, 2015.

Kindly take the above information on record

Thanking you Yours faithfully,

For SMS Pharmaceuticals Limited

v S Venkatish Company Secretary

_ .. .ib~ 12 a>BQ')e> 2 021 . -.-

, a SMS PHARMACEUTICALS LIMITED

CIN:L24239TG1981PLCOO8086, ~ms Regd. OffIce: Plot No. 72. H.No: 8-2-334/3 & 4, Road No.5. Opp. S81 Executive Enclave, BanJara Hills, Hyderabad T6 500034 Phone: 040-3535!!999, Fal(:040-25259889, Email:cs@smsphannacom, www.smspharma.com

	~	~~~etQ			_~CIIfilIS
~			~II- lIIlII:.iI.-		twIIU.-		~p.I:>4Io
iI>o					81.12.2020 31.12.2820 31.12.2019 31.12.2020 31.12.2820		31.12.2019
					(eoS4If~ eoS4If~ {eSiII~ eoS4If~) eoS4If~ (eoS4If~)
1	tt.1<>4 <l1Ȥo-()< td="">14972.3439404.038124.0514972.3339404.038124.05</l1Ȥo-(~)<>	14972.34	39404.03	8124.05	14972.33	39404.03	8124.05
	2 ~"""'~~tt.1<>4 <joc1o< td="">2.674.645,681.131,249.872,674.645,681.131,249.87</joc1o<>	2.674.64	5,681.13	1,249.87	2,674.64	5,681.13	1,249.87
	3 ~~~~I6>oA <jocio(-< td="">1832.153875.14750.032139.353938.98761.73</jocio(-<>	1832.15	3875.14	750.03	2139.35	3938.98	761.73
4	<liȤo-~ 811)1i="">(~ 00Q0)8'IlII>~~~ .,_)</liȤo~-~>	1.829.58	3.868.10	747.50	2.137.23	3.933.24	759.60
5	1II¥_~~m,.>_G>t.1 -~)	846.52	846.52	846.52	846.52	846.52	846.52
	~6 ~~BIOtloo.IJtA!II-1SJo.	-		-
	--7 i)6-)
	~itbl ll»O.	2.16	4.58	0.89	2.53	4.65	0.90

I

1. I!IO~ 11 a\lC<J1l) ~Oifim ~ ~ ea.5a\lC<J1l)~~a\lC<J1l) 10~. 202116 di6iJOt) ~ ~~~~a\lC<J1l) ~dh>!~~~~~.

2- III~~~ 2013 db.ll~ 133a\lC<J1l)~~~IlQOOJIt.Il~~~~~~ e1Po&II 2015 aoai~~.

1. SEBI ) ~ 2015db.ll~ 33 ¥ 0ft)4iI ~ ~ IilJIflP ~ ~~ ~ <ihlIIa.~ i!I6 ~ ~ Iti1IO..p ~ ~ <ihlIIa.~ ~ ~ ",OIl ~ ~ www.bseindia.com (10 53281 5) b ~ (www.nseindia.com) a\lC<J1l)~~ (www.SMSPHARMAcom)i! ~~.

By order of the Board For SMS Pharmlceutlc8l. UmHed Ramah Babu PolIuri Place: Hyderabad Chalnnan & Managing 'DIrector Date: 11.02. 2021 (OIN:00188381 )

.• ~

FRIDAY, FEBRUARY 12, 2021 . WWW.FINANCIALEXPRESS.COM

FINANCIAl.. EX PRES ~-- - - .. rI. . - . ---c '" ;:!.J" , '-- 'J

~ SMS PHARMACEUTICALS LIMITED sms CIN:L24239TG1987PLC008066,

Regd. Office : Plot No. 72, H.No: 8-2-334/3 & 4, Road No.5, Opp. SBI Executive Enclave, Banjara Hills, Hyderabad TG 500034 Phone: 040·35359999, Fax:040-25259889, Email:cs@smspharma.com, www.smspharma.com

	Extract of Financial Results for the Quarter and nine months Ended 31 st December, 2020						(~In Lakhs)
	Particulars	Standalone			Consolidated
SI.No.			Quarter ended 9 Monls ended Quarter ended			Quarter ended 9 Months ended Quarter ended
		31.12.2020		31.12.2020 31.12.2019 31 .12.2020 31.12.2020			31.12.2019

						(Unaudited)
1 Total Income .from Operations (net)	14,972.34	39,404.03	8.124.05	14,972.33	39,404.03	8,124.05
2 -Profit from Ordinary Activities before Tax	2,674.64	5.681 .13	1,249.87	2.674.64	5,681.13	1.249.87
3 Profit from Ordinary Activities after Tax (after Extraordinarv Items)	1832.15	3875.14	750.03	2139.35	3938.98	761.73
4 Total Comprehensive Income for the quarter (comprising profit/Loss) for
the Quarter (after tax) and other comprehensive items)	1829.58	3868.10	747.50	2137.23	3933.24	759.60
5 Equity Share Capital (Face value of share: Re.1/· each)	846.52	846.52	846.52	846.52	846.52	846.52
6 Reserves (excluding Revaluation Reserve as per Balance Sheet) Re. 1/- each
7 Earnings per share (before extraordinary items· (Not annualized)
a) Basic/Diluted (in Rs)	2.16	4.58	0.89	2.53	4.65	0.90
						(Unaudited) (unaudlled) (Unaudlled) (Unaudlled) (Unaudited)

Noles:

1 The above Standalone and consolidated Financial Results have been reviewed and recommended by the Audit Committee and approved by the Board of Directors in their meetings held on 10th February, 2021 and Statutory Auditors of the Company have carried outa Limited Review.

2 These results have been prepared in accordance with the Companies (Indian Accounting Standards) Ru les,2015 (Ind AS) prescribed Under Section 1330lthe Companies Act.2013 and other recognized accounting practices and policies to the extent applicable.

3 The above is an extract of detailed format of quarterly / annual financial results filed with the stock exchanges under regulation 33 of the SEBI (LODR) Regulations, 2015. The full format of quarterly / annual financial results are available on the website of the Stock Exchanges of BSE www.bseindia.com(ID 532815) or NSE (www.nseindia.com) and companies website (www.SMSPHARMA.com) .. By order of the Board

For SMS Pharmaceuticals limited Ramesh Babu Polluri Place: Hyderabad Chairman & Managing Director Date: 11.02. 2021 (DlN:00166381 ) .-